Core Viewpoint - Baijin Life Sciences (01466.HK) has signed a strategic cooperation framework agreement with Shanghai GuHuan Medical Equipment Co., Ltd. to invest in the latter through equity subscription, aiming to establish direct sales channels for branded medical products [1] Group 1: Investment and Partnership - Baijin will invest in GuHuan Medical to enhance its sales channels for medical products [1] - The cooperation framework agreement is set to expire on December 31, 2026, with provisions for early termination by either party with a 10-day notice [1] Group 2: Management and Expertise - Liang Liang will be appointed as the director of the medical division, responsible for the expansion of medical products [1] - GuHuan Medical has over ten years of experience in the medical product supply chain and holds stakes in more than thirty medical beauty institutions [1] - Liang has extensive experience in the medical beauty industry, covering supply chain, medical institution operations, and investment management [1] Group 3: Strategic Goals - The board believes that the agreement will help the company build a comprehensive market ecosystem for medical products, from research and development to self-owned sales channels [1] - The partnership is expected to stabilize and expand the company's revenue sources [1]
佰金生命科学(01466.HK)战略投资谷环医疗 构建集团品牌医疗产品直营门店销售渠道